病毒安全 病毒安全
Ken Kono1, Satoshi Yasuda1, Yoji Sato2
1Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan.
Advances in experimental medicine and biology
|October 24, 2025
概括
确保病毒安全对于细胞疗法产品至关重要,以防止患者受到伤害. 先进的技术,如下一代测序,对于这个领域的强有力的病毒安全评估至关重要.
科学领域:
- 生物技术是生物技术.
- 细胞疗法细胞疗法
- 病毒学 病毒学
背景情况:
- 病毒污染对接受细胞治疗的患者构成重大风险.
- 确保产品安全对于细胞疗法的临床应用至关重要.
- 保护公共健康需要严格的病毒安全评估.
研究的目的:
- 概述一种基本策略,以确认细胞治疗产品中的病毒安全性.
- 介绍使用下一代测序进行病毒安全性评估的最新进展.
- 解决共同和特定产品的病毒安全措施的需求.
主要方法:
- 审查当前的科学文献和病毒安全的技术进步.
- 实施下一代测序以提高病毒检测能力.
- 开发独特的细胞疗法产品的个案方法.
主要成果:
- 建立了一种系统方法,用于在细胞疗法中确认病毒安全性.
- 证明了下一代测序在识别病毒污染物的有用性.
- 强调了适应性安全协议对于各种细胞产品的重要性.
结论:
- 先进的科学方法对于确保细胞治疗产品的病毒安全至关重要.
- 下一代测序为全面的病毒安全测试提供了强大的工具.
- 为了有效的病毒安全管理,必须结合标准化和量身定制的方法.
相关概念视频
Subviral Agents
512
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
512
Viral Mutations
39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K


